128053-53-2

Basic information

• Product Name: 1-methylethyl 4-cyclohexyl-2-hydroxy-3-({N-[(2R)-4-morpholin-4-yl-2-(naphthalen-1-ylmethyl)-4-oxobutanoyl]-L-histidyl}amino)butanoate
• Synonyms: cyclohexanebutanoic acid, alpha-hydroxy-beta-[[(2S)-3-(1H-imidazol-4-yl)-2-[[(2R)-4-(4-morpholinyl)-2-(1-naphthalenylmethyl)-1,4-dioxobutyl]amino]-1-oxopropyl]amino]-, 1-methylethyl ester, (alphaS)-; propan-2-yl (2S)-4-cyclohexyl-2-hydroxy-3-({N-[(2R)-4-(morpholin-4-yl)-2-(naphthalen-1-ylmethyl)-4-oxobutanoyl]-L-histidyl}amino)butanoate
• CAS NO: 128053-53-2
• Molecular Formula: C₃₈H₅₁N₅O₇
• Molecular Weight: 689.8408
• Mol File: 128053-53-2.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 1005.1°C at 760 mmHg
• Flash Point: 561.7°C
• Density: 1.234g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.589
• CAS DataBase Reference: 1-methylethyl 4-cyclohexyl-2-hydroxy-3-({N-[(2R)-4-morpholin-4-yl-2-(naphthalen-1-ylmethyl)-4-oxobutanoyl]-L-histidyl}amino)butanoate(CAS DataBase Reference)
• NIST Chemistry Reference: 1-methylethyl 4-cyclohexyl-2-hydroxy-3-({N-[(2R)-4-morpholin-4-yl-2-(naphthalen-1-ylmethyl)-4-oxobutanoyl]-L-histidyl}amino)butanoate(128053-53-2)
• EPA Substance Registry System: 1-methylethyl 4-cyclohexyl-2-hydroxy-3-({N-[(2R)-4-morpholin-4-yl-2-(naphthalen-1-ylmethyl)-4-oxobutanoyl]-L-histidyl}amino)butanoate(128053-53-2)

Safety Data

• Hazardous Substances Data: 128053-53-2(Hazardous Substances Data)

Usage

Isopropyl group

A secondary alkyl group (1-methylethyl) attached to the main structure, which may influence the compound's steric properties and reactivity.

Cyclohexyl ring

A six-membered saturated carbon ring, which provides a cyclic structure that can participate in pi-pi interactions and hydrogen bonding.

Hydroxy group

A polar, hydrophilic functional group that can form hydrogen bonds and may be involved in solvation and interactions with biological targets.

Morpholin-4-yl group

A heterocyclic ether with a nitrogen atom in the ring, which can participate in hydrogen bonding and may contribute to the compound's solubility and biological activity.

Naphthalen-1-ylmethyl group

An aromatic alkyl group derived from naphthalene, which may contribute to the compound's lipophilicity and interactions with biological targets.

Oxobutanoyl group

A carbonyl-containing acyl group, which can participate in hydrogen bonding and may be involved in binding interactions with biological systems.

Histidyl amino acid residue

An amino acid side chain with a heterocyclic imidazole ring, which can coordinate with metal ions and participate in hydrogen bonding, making it a potential site for interactions with biological targets and a key feature for pharmaceutical or biological applications.

Upstream product

• 115131-67-4 (S)-3-(1H-Imidazol-4-yl)-2-((R)-4-morpholin-4-yl-2-naphthalen-1-ylmethyl-4-oxo-butyrylamino)-propionic acid 
• 113724-12-2 N-[(2R)-3-(Morpholinocarbonyl)-2-(1-naphthylmethyl)-propionyl]-L-histidine Methyl Ester 
• 66-77-3 1-naphthaldehyde 
• 121506-22-7 (2R,3S)-nor-C-statine hydrochloride 
• 119434-65-0 (2R)-3-(Morpholinocarbonyl)-2-(1-naphthylmethyl)-propionic acid 
• 106868-59-1 3-(Morpholinocarbonyl)-2-(1-naphthylmethylidene)propionic acid 
• 125702-08-1 2-(1-Naphthylmethylidene)succinic Acid 
• 115131-71-0 2(R)-Hydroxy-3(S)-amino-4-cyclohexylbutanoic acid, 2-propanol ester, hydrochloride 
• 130737-73-4 N-<(2R)-2-morpholinocarbonylmethyl-3-(1-naphthyl)propionyl>-N^im-Boc-L-histidine 

Relevant articles and documents

Orally Potent Human Renin Inhibitors Derived from Angiotensinogen Transition State: Design, Synthesis, and Mode of Interaction

A three-dimensional structure of the complex of human renin and the scissile site P4 Pro to P1' Val of angiotensinogen was deduced in order to design potent human renin inhibitors rationally.On the basis of this structure, an orally

Design and synthesis of an orally potent human renin inhibitor containing a novel amino acid, cyclohexylnorstatine

-